Recent studies with a number of microbial pathogens, including Leishmania major, Cryptococcus neoformans, Mycobacterium tuberculosis, and Toxoplasma gondii, have established the critical role of nitric oxide (NO) and other reactive nitrogen intermediates in the microbicidal activity of cytokine-stimulated murine macrophages (reviewed in reference 8). Although increased production of NO is responsible for heightened microbicidal activity, in some cases a small number of microorganisms can persist, leading to a subpatent infection and possibly chronic sequelae. Increasing the level of NO production by macrophages may lead to enhanced microbial killing and even the complete elimination of intracellular microorganisms. Using the protozoan parasite Trypanosoma cruzi as a model, we tested the effect of providing increased levels of substrate for NO biosynthesis on the microbicidal activity of gamma interferon (IFN-␥)-activated murine macrophages.
T. cruzi is the causative agent of Chagas' disease, which is a major public health concern in rural areas of Central and South America, where it is estimated that 16 to 18 million people are currently infected. Infectious trypomastigotes are introduced into the vertebrate host by insect vectors and infect a number of cell types, including macrophages. Macrophage activation by IFN-␥ is a critical factor in controlling the infection and in clearance of the organisms. IFN-␥ treatment increases survival of acutely infected mice and enhances trypanocidal activity of activated macrophages. Although there is an increase in IFN-␥ levels early in the host response to T. cruzi infections, it is apparently insufficient for complete clearance of the parasites (18) . IFN-␥-treated murine peritoneal macrophages and human monocytes exhibit increased killing of T. cruzi amastigotes, attributable to NO production via an Larginine dependent pathway (5, 11) . In addition, increased NO levels correlated with reduced parasitemias in experimentally infected mice (13) , and treatment of experimentally infected mice with inhibitors of nitric oxide sythase exacerbated the infection (19) . These results suggest that augmentation of macrophage microbicidal activity, specifically through the increased generation of NO, represents a previously unexplored avenue through which early control of the infection may be achieved.
The production of NO by activated macrophages is the result of increased expression of the inducible isoform of nitric oxide synthase (iNOS), which produces NO and citrulline from arginine. Once iNOS is expressed, the level of NO production is dependent in part upon the concentration of arginine, which is the only physiologic nitrogen donor for NO production (reviewed in reference 10). Previous studies have shown that physiologic levels of arginine are rate limiting for NO production (9, 12) and that citrulline, the byproduct of NO production, can be recycled to arginine via argininosuccinate synthetase (AS) and argininosuccinate lyase, thus increasing the available arginine for NO production in activated iNOS-expressing cells (12, 20) . The arginine biosynthetic enzyme AS and iNOS are coinduced upon stimulation of a macrophage cell line with IFN-␥ or lipopolysaccharide (LPS), and coinduction correlates with increased enzymatic activity and NO production (12) . Taken together, these results suggest that NO production and arginine biosynthesis are coupled and that increased extracellular arginine or citrulline could support increased NO production in an IFN-␥-activated macrophage cell line (10) .
The present study addresses three major questions. (i) What is the extent of NO-dependent killing of T. cruzi by activated macrophages at physiologic levels of arginine? (ii) Do increases in extracellular arginine concentration above the physiologic level significantly increase killing of T. cruzi in activated macrophages? (iii) Is citrulline, via recycling to arginine, effec-tive in enhancing NO production and intracellular killing of T. cruzi by activated macrophages?
To determine if increasing extracellular arginine or citrulline levels represented an effective means of increasing macrophage NO production, thioglycolate-elicited peritoneal exudate cells were recovered from female BALB/c mice (Jackson Laboratory, Bar Harbor, Maine) and plated at 2.5 ϫ 10 5 cells per well in 96-well microtiter plates (Corning, Corning, N.Y.) at 37ЊC in 5% CO 2 in Dulbecco's modified Eagle medium (GIBCO, Grand Island, N.Y.) containing 10% fetal bovine serum, 2 mM glutamine, 10 mM HEPES (N-2-hydroxyethylpiperazine-NЈ-2-ethanesulfonic acid), 1% modified Eagle medium nonessential amino acids, 5% NCTC-109, and 50 g of gentamicin per ml (all from GIBCO). After 4 h, nonadherent cells were removed by washing with supplemented RPMI Select-Amine (GIBCO) medium (with 10% fetal bovine serum, 2 mM glutamine, 10 mM HEPES and 50 g of gentamicin per ml) containing 80 M arginine. The medium was then replaced with RPMI Select-Amine medium containing various levels of arginine or citrulline as indicated in Fig. 1 . All citrulline-supplemented media contained 80 M arginine, which represents physiologic levels in plasma (3, 17) . IFN-␥ (Genentech, San Francisco, Calif.) was added to each well at 100 U/ml, and the plates were incubated for 18 h at 37ЊC in 5% CO 2 . The plates were washed twice, and the medium was replaced with fresh arginine-or citrulline-supplemented complete RPMI Select-Amine medium. Tissue culture-derived trypomastigotes (strain Y) were harvested as previously described (16) and added to the wells at a multiplicity of infection of 5. After 6 h, extracellular trypomastigotes were removed by washing the macrophages twice. The medium was replaced with complete RPMI Select-Amine medium containing 10 ng of LPS (Sigma Chemical Co., St. Louis, Mo.) per ml and arginine or citrulline as indicated in Fig. 1 . The cells were incubated at 37ЊC in 5% CO 2 for 72 h. Infection levels were assessed microscopically by staining the cells with Diff-quik (Baxter, McGaw Park, Ill.) and counting the number of infected cells in 10 random fields (ϫ400 magnification) in triplicate sets for each experimental condition. Additionally, the number of amastigotes per cell was quantitated by counting the number of parasites in 30 random infected cells for each condition. For each culture condition NO 2 Ϫ was measured in the culture supernatants as an indicator of NO production by a modified Griess assay as described elsewhere (7) . Under the culture conditions described above, intracellular amastigotes were readily detectable 72 h after infection. Infection of peritoneal macrophages in the presence of 80 M arginine without prior activation with IFN-␥ and LPS resulted in a heavily infected culture (Ͼ50% infected cells) without detectable NO production (not shown). Thus, the parasites themselves do not appear to stimulate NO production in these cells. When the cells were activated and then cultured in media containing increasing levels of arginine, a dose-dependent increase in NO production was observed up to 1 mM arginine, indicating that under physiologic conditions, arginine is limiting for NO production by IFN-␥-activated peritoneal macrophages (Fig. 1) . The results shown represent the mean NO 2 Ϫ levels at 72 h postinfection of triplicate samples from six independent experiments.
Because activated macrophages can also produce arginase which will suppress NO production by hydrolyzing extracellular arginine (1, 4), we investigated whether citrulline could replace arginine in augmenting NO production. Our results demonstrate that at levels as low as 80 M, citrulline can augment NO production in activated peritoneal macrophages over the background level of 80 M arginine (Fig. 1) and that cells in arginine-and citrulline-supplemented media produced comparable levels of NO over the range of concentrations tested.
The trypanocidal activity of activated macrophages in the presence of increased arginine and citrulline also increased dramatically. We consistently observed that once NO 2 Ϫ levels exceeded 75 M, the infections were completely cleared or prevented. The NO produced under these conditions did not affect cell adherence in the cultures observed after 72 h, indicating that it is still below cytotoxic levels (not shown). These results were consistent in six independent experiments, with the results of a representative experiment shown in Table 1 . At arginine and citrulline concentrations of 320 M, there was a significant decrease in the number of infected cells, as well as the number of parasites per cell compared with numbers in controls ( Table 1) . These results suggest that there is a critical threshold level of NO which can completely eliminate the infection in activated macrophages in vitro but that physiologic levels of arginine are probably limiting for NO production and therefore this level may not be attained during the course of an infection. This may be a critical feature in the pathogenesis of T. cruzi infections, since parasites may persist at very low levels and contribute to the development of chronic disease.
To establish that the trypanocidal activity observed was attributable to arginine-dependent NO production, N G -monomethyl-L-arginine (NMMA) (Calbiochem, La Jolla, Calif.), an inhibitor of iNOS, was added to the cultures at the initiation of infection. At all arginine and citrulline levels, NMMA (500 M) completely inhibited NO production (not shown) and the trypanocidal activity was completely abrogated (Table 1) . These results clearly show that the effect of supplemental arginine and citrulline on trypanocidal activity of activated macrophages is the result of increased NO production by these cells. The high efficiency of citrulline in supporting NO production is likely a consequence of the fact that mRNA encod- ing AS, the rate-limiting enzyme in arginine biosynthesis, is coinduced with iNOS mRNA in these cells (Fig. 2) . Together, these results support the conclusion that arginine biosynthesis and NO production are coordinately regulated in these cells as in other cell types (10) , so that supplemental citrulline is efficiently recycled to arginine, thus boosting NO production and parasite killing. The results presented here confirm the critical role of NO in mediating trypanocidal activity of activated macrophages and demonstrate that physiologic levels of arginine are limiting for NO production and parasite killing by IFN-␥-activated peritoneal macrophages. Modest increases in arginine concentration above physiologic levels blocked infection with T. cruzi in vitro. Furthermore, citrulline could effectively replace arginine as a means of boosting production of NO by activated macrophages, thus demonstrating an active arginine biosynthetic pathway in these cells.
Previous studies have shown that levels of arginine in plasma may be increased by dietary supplementation (2, 6, 14, 15) , suggesting that, on the basis of our results, dietary supplementation with arginine or citrulline may be an effective way to boost NO production in vivo. Because citrulline was shown to be nearly as effective as arginine in supporting NO production and it is not a substrate for arginase, delivery of this amino acid may be particularly effective in enhancing microbicidal activity of activated macrophages in vivo. The present study indicates that modulation of macrophage function by increasing the availability of arginine for iNOS may represent a means of early and efficient control of infectious agents known to be susceptible to NO toxicity. 
